Halozyme Therapeutics, Inc. (HALO)
76.92
-2.59
(-3.26%)
USD |
NASDAQ |
Feb 12, 16:00
77.00
+0.08
(+0.10%)
After-Hours: 17:55
Halozyme Therapeutics Market Cap : 9.046B for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 589.10B |
| Merck & Co., Inc. | 296.06B |
| AIM ImmunoTech, Inc. | 2.759M |
| Stryker Corp. | 139.92B |
| Skye Bioscience, Inc. | 23.44M |
Market Cap Related Metrics
| PE Ratio | 16.17 |
| PS Ratio | 7.769 |
| PEG Ratio | 0.2815 |
| Price to Book Value | 17.95 |
| Price to Free Cash Flow | 16.03 |
| Price | 76.92 |
| Earnings Yield | 6.18% |
| PEGY Ratio | 0.2815 |
| Operating PE Ratio | 13.09 |
| Normalized PE Ratio | 16.17 |